More News

23 Jan 2007 Wockhardt signs in-licensing pact with Crawford Healthcare of UK, Launches Vitix for vitiligo skin disorder
23 Jan 2007 Shire licenses the North American rights for SPD754 (apricitabine) to Avexa Ltd
23 Jan 2007 Hikma expands into the oncology market
20 Jan 2007 Penwest Begins Next Study in Development of Nalbuphine ER
20 Jan 2007 Bayer Schering Pharma to develop new imaging compounds for detection of Neurodegenerative Diseases
19 Jan 2007 Alexza Completes Enrollment in AZ-004 Phase IIa Clinical Trial in Schizophrenic Patients with Acute Agitation
19 Jan 2007 Adherex Buys Out Eniluracil Development Options From GlaxoSmithKline
19 Jan 2007 Barr Laboratories Receives Tentative Approval For Generic KYTRIL(R) Tablets, 1mg (Base)
18 Jan 2007 Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
18 Jan 2007 Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
18 Jan 2007 XOMA and Schering-Plough Add New Programs to Antibody Collaboration
17 Jan 2007 Hana Biosciences Receives Orphan Drug Designation for Marqibo (Vincristine Sulfate Liposomes Injection) for the Treatment of Acute Lymphoblastic Leukemia
17 Jan 2007 Genizon Biosciences Announces a License and Collaboration Agreement with Pfizer in Three Major Diseases
17 Jan 2007 DOV Pharmaceutical Announces Exclusive Agreement for the Development and Commercialization of Bicifadine
17 Jan 2007 Marketing License Granted in The Netherlands for Adult Patients with Depression
17 Jan 2007 DanioLabs and Senexis Announce Collaboration on Ageing Related Diseases
17 Jan 2007 Merrion Announces Positive Clinical Results for Osteoporosis Drug MER 103
13 Jan 2007 Bioxell Acquires Novel Compound from Roche
13 Jan 2007 BioInvent enters collaboration with Genentech to develop and commercialize BioInvent's proprietary antibody for the potential treatment of cardiovascular diseases
13 Jan 2007 Nicholas Piramal announces Drug Development Agreement with Eli Lilly and Company.
13 Jan 2007 Biocoral, Inc. Announces the Results of the Final Report of its Prospective Randomised Clinical Multi-Centre Trial for Treatment of Hip Fractures Associated With Natural Bone Demineralization/or Low Bone Mass
13 Jan 2007 Biocoral, Inc. Announces the Results of the Final Report of its Prospective Randomised Clinical Multi-Centre Trial for Treatment of Hip Fractures Associated With Natural Bone Demineralization/or Low Bone Mass
12 Jan 2007 Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to Develop and Commercialize Diabetes Compounds
12 Jan 2007 Immuno-Biological Laboratories Co., Ltd. and Intellect Neurosciences, Inc. Enter into Humanized Monoclonal Antibodies Development Agreement for the Treatment of Alzheimer's Disease
12 Jan 2007 KINAXO Announces Agreement with Johnson & Johnson

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top